Vaishali Pharma

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	75.09	67.76	63.97	66.71	94.56
Other Income	1.98	1.66	0.93	3.18	4.26
Stock Adjustments	-0.89	0.71	-2.21	0.04	-4.83
Total Income	76.18	70.13	62.69	69.93	93.99
EXPENDITURE :
Raw Materials	67.78	60.61	53.94	62.07	86.42
Excise Duty	0	0	0	0	0
Power and Fuel Cost	0	0	0	0	0
Other Manufacturing Expenses	0.03	0.06	0.36	0	0
Employee Cost	2.13	2.04	1.59	1.56	1.85
Selling and Administration Expenses	2.18	2.97	2.38	0	0
Miscellaneous Expenses	0.04	0.01	0.03	2.57	1.75
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	4.04	4.45	4.41	3.73	3.97
Interest and Financial Charges	2.64	2.85	3.1	3.37	3.37
Profit before Depreciation and Tax	1.4	1.6	1.31	0.36	0.6
Depreciation	0.27	0.25	0.28	0.37	0.45
Profit Before Tax	1.13	1.35	1.03	0	0.15
Tax	0.42	0.55	0.32	0.03	-0.01
Profit After Tax	0.71	0.8	0.71	-0.03	0.16
Adjustment below Net Profit	0	0	-2.49	0	0
P and L Balance brought forward	1.77	0.97	2.75	2.74	2.57
Appropriations	0	0	0	0	0
P and L Bal. carried down	2.49	1.77	0.97	2.7	2.74
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	0	0	0	0	0
Earning Per Share (Rs.)	1.08	1.21	2.37	0	3.23
Book Value	32.47	31.26	13.25	64.09	64.7
Extraordinary Items	0	0	0	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

75.09

67.76

63.97

66.71

94.56

Other Income

1.98

1.66

0.93

3.18

4.26

Stock Adjustments

-0.89

0.71

-2.21

0.04

-4.83

Total Income

76.18

70.13

62.69

69.93

93.99

EXPENDITURE :

Raw Materials

67.78

60.61

53.94

62.07

86.42

Excise Duty

Power and Fuel Cost

Other Manufacturing Expenses

0.03

0.06

0.36

Employee Cost

2.13

2.04

1.59

1.56

1.85

Selling and Administration Expenses

2.18

2.97

2.38

Miscellaneous Expenses

0.04

0.01

0.03

2.57

1.75

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

4.04

4.45

4.41

3.73

3.97

Interest and Financial Charges

2.64

2.85

3.1

3.37

Profit before Depreciation and Tax

1.4

1.6

1.31

0.36

0.6

Depreciation

0.27

0.25

0.28

0.37

0.45

Profit Before Tax

1.13

1.35

1.03

0.15

Tax

0.42

0.55

0.32

0.03

-0.01

Profit After Tax

0.71

0.8

0.71

-0.03

0.16

Adjustment below Net Profit

-2.49

P and L Balance brought forward

1.77

0.97

2.75

2.74

2.57

Appropriations

P and L Bal. carried down

2.49

1.77

0.97

2.7

2.74

Equity Dividend

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

1.08

1.21

2.37

3.23

Book Value

32.47

31.26

13.25

64.09

64.7

Extraordinary Items

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	6.59	6.59	3	0.5	0.5
Reserves and Surplus	14.81	14.01	0.97	2.7	2.74
Total Shareholders Funds	21.4	20.6	3.97	3.2	3.24
Secured Loans	16.72	15.77	16.44	15.29	15.83
Unsecured Loans	0.45	2.81	6.62	5.92	9.4
Total Debt	17.17	18.58	23.06	21.21	25.23
Total Liabilities	38.57	39.18	27.03	24.41	28.47
APPLICATION OF FUNDS :
Gross Block	2.14	1.79	1.57	2.51	2.42
Less: Accum. Depreciation	0.8	0.53	0.28	1.11	0.74
Net Block	1.34	1.26	1.29	1.4	1.68
Capital Work in Progress	0.04	0.08	0	0	0
Investments	0.43	0.43	0.38	0.38	0.38
Current Assets, Loans and Advances
Inventories	0.98	1.87	1.15	3.36	3.32
Sundry Debtors	49.42	44.58	37.47	40.42	34.36
Cash and Bank Balance	0.32	0.28	0.18	1.05	1.01
Loans and Advances	16.23	15.72	4.4	2.82	5.05
Less: Current Liab. and Prov.
Current Liabilities	29.44	24.66	17.44	24.69	17.18
Provisions	0.74	0.39	0.39	0.31	0.16
Net Current Assets	36.77	37.4	25.37	22.65	26.4
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	38.58	39.17	27.04	24.43	28.46
Contingent Liabilities	0	0	0	0.38	0.32

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

6.59

0.5

Reserves and Surplus

14.81

14.01

0.97

2.7

2.74

Total Shareholders Funds

21.4

20.6

3.97

3.2

3.24

Secured Loans

16.72

15.77

16.44

15.29

15.83

Unsecured Loans

0.45

2.81

6.62

5.92

9.4

Total Debt

17.17

18.58

23.06

21.21

25.23

Total Liabilities

38.57

39.18

27.03

24.41

28.47

APPLICATION OF FUNDS :

Gross Block

2.14

1.79

1.57

2.51

2.42

Less: Accum. Depreciation

0.8

0.53

0.28

1.11

0.74

Net Block

1.34

1.26

1.29

1.4

1.68

Capital Work in Progress

0.04

0.08

Investments

0.43

0.38

Current Assets, Loans and Advances

Inventories

0.98

1.87

1.15

3.36

3.32

Sundry Debtors

49.42

44.58

37.47

40.42

34.36

Cash and Bank Balance

0.32

0.28

0.18

1.05

1.01

Loans and Advances

16.23

15.72

4.4

2.82

5.05

Less: Current Liab. and Prov.

Current Liabilities

29.44

24.66

17.44

24.69

17.18

Provisions

0.74

0.39

0.31

0.16

Net Current Assets

36.77

37.4

25.37

22.65

26.4

Miscellaneous Expenses not w/o

Total Assets

38.58

39.17

27.04

24.43

28.46

Contingent Liabilities

0.38

0.32

Vaishali Pharma

Enjoy Lifetime Free Delivery Trade